QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
NASDAQ:DRS

Leonardo DRS (DRS) Stock Forecast, Price & News

$15.50
+0.17 (+1.11%)
(As of 06/2/2023 ET)
Compare
Today's Range
$15.40
$15.65
50-Day Range
$11.60
$15.77
52-Week Range
$9.11
$15.90
Volume
452,221 shs
Average Volume
662,764 shs
Market Capitalization
$4.05 billion
P/E Ratio
7.18
Dividend Yield
N/A
Price Target
$17.67

Leonardo DRS MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
14.4% Upside
$17.67 Price Target
Short Interest
Bearish
5.67% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.26mentions of Leonardo DRS in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.67 out of 5 stars

Aerospace Sector

36th out of 45 stocks

Search & Navigation Equipment Industry

8th out of 10 stocks


DRS stock logo

About Leonardo DRS (NASDAQ:DRS) Stock

Leonardo DRS, Inc. engages in the provision of defense products and technologies. It develops and manufactures defense products for the U.S. military, intelligence agencies and allies around the world. Its broad technology portfolio focuses on advanced sensing, network computing, force protection, and electrical power and propulsion, as well as a range of key defense priorities. The company operates through two segments: Advanced Sensors & Computing, and Integrated Mission Systems. The Advanced Sensors & Computing segment has been aligned to push towards a more autonomous future. It consists of six business units, which include Airborne & Intelligence Systems, Daylight Solutions, DRS RADA Technologies, Electro-Optical & Infrared Systems, Land Electronics, and Naval Electronics. The Integrated Mission Systems segment consists of both a ground vehicle integrator and naval power and propulsion system provider. Leonardo DRS was founded by Leonard Newman and David E. Gross in 1969 and is headquartered in Arlington, VA.

Receive DRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Leonardo DRS and its competitors with MarketBeat's FREE daily newsletter.

DRS Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Leonardo DRS (NASDAQ:DRS) Sees Strong Trading Volume
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Leonardo DRS (DRS) Set to Announce Earnings on Wednesday
Microbolometer Market Research Analysis 2023-2031
Leonardo DRS: Order Backlog Already Priced In
Leonardo DRS (NASDAQ:DRS) Trading Down 2.9%
See More Headlines

DRS Price History

DRS Company Calendar

Today
6/02/2023
Next Earnings (Estimated)
8/16/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Search & navigation equipment
Sub-Industry
N/A
Sector
Aerospace
Current Symbol
NASDAQ:DRS
Employees
6,400
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$17.67
High Stock Price Forecast
$19.00
Low Stock Price Forecast
$17.00
Forecasted Upside/Downside
+14.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$405 million
Pretax Margin
24.09%

Debt

Sales & Book Value

Annual Sales
$2.69 billion
Cash Flow
$0.96 per share
Book Value
$8.21 per share

Miscellaneous

Free Float
258,390,000
Market Cap
$4.03 billion
Optionable
Optionable
Beta
0.87

Key Executives

  • William J. Lynn
    Chairman & Chief Executive officer
  • John A. Baylouny
    Chief Operating Officer & Executive Vice President
  • Michael D. Dippold
    Chief Financial Officer & Executive Vice President
  • Philip Perconti
    Chief Technology Officer
  • Mark A. Dorfman
    Secretary, Executive VP & General Counsel













DRS Stock - Frequently Asked Questions

Should I buy or sell Leonardo DRS stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Leonardo DRS in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" DRS shares.
View DRS analyst ratings
or view top-rated stocks.

What is Leonardo DRS's stock price forecast for 2023?

4 analysts have issued 12 month price objectives for Leonardo DRS's shares. Their DRS share price forecasts range from $17.00 to $19.00. On average, they anticipate the company's share price to reach $17.67 in the next twelve months. This suggests a possible upside of 14.4% from the stock's current price.
View analysts price targets for DRS
or view top-rated stocks among Wall Street analysts.

How have DRS shares performed in 2023?

Leonardo DRS's stock was trading at $12.78 on January 1st, 2023. Since then, DRS stock has increased by 20.8% and is now trading at $15.44.
View the best growth stocks for 2023 here
.

When is Leonardo DRS's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 16th 2023.
View our DRS earnings forecast
.

What guidance has Leonardo DRS issued on next quarter's earnings?

Leonardo DRS issued an update on its FY 2023 earnings guidance on Wednesday, March, 29th. The company provided EPS guidance of $0.64-$0.69 for the period, compared to the consensus earnings per share estimate of $0.74. The company issued revenue guidance of $2.70 billion-$2.80 billion, compared to the consensus revenue estimate of $2.83 billion.

When did Leonardo DRS IPO?

(DRS) raised $670 million in an initial public offering (IPO) on Wednesday, March 24th 2021. The company issued 31,900,000 shares at $20.00-$22.00 per share. Goldman Sachs, BofA Securities, J.P.Morgan, Barclays, Citigroup, Credit Suisse and Morgan Stanley served as the underwriters for the IPO and Credit Agricole CIB, IMI - Intesa Sanpaolo, MUFG and UniCredit Capital Markets were co-managers.

What is Leonardo DRS's stock symbol?

Leonardo DRS trades on the NASDAQ under the ticker symbol "DRS."

Who are Leonardo DRS's major shareholders?

Leonardo DRS's stock is owned by many different institutional and retail investors. Top institutional investors include Wellington Management Group LLP (1.61%), Macquarie Group Ltd. (1.23%), Macquarie Group Ltd. (1.23%), Boston Partners (0.89%), Stephens Investment Management Group LLC (0.65%) and Royce & Associates LP (0.64%).

How do I buy shares of Leonardo DRS?

Shares of DRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Leonardo DRS's stock price today?

One share of DRS stock can currently be purchased for approximately $15.44.

How much money does Leonardo DRS make?

Leonardo DRS (NASDAQ:DRS) has a market capitalization of $4.03 billion and generates $2.69 billion in revenue each year. The company earns $405 million in net income (profit) each year or $2.16 on an earnings per share basis.

How many employees does Leonardo DRS have?

The company employs 6,400 workers across the globe.

How can I contact Leonardo DRS?

Leonardo DRS's mailing address is 7 GIBOREI ISRAEL STREET P.O. BOX 8606, NETANYA L3, 4250407. The official website for the company is www.rada.com. The company can be reached via phone at (703) 416-8000, via email at rada@gkir.com, or via fax at 972-9885-5885.

This page (NASDAQ:DRS) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -